These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 24732212

  • 1. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
    Martín R, Cordova C, San Román JA, Gutierrez B, Cachofeiro V, Nieto ML.
    J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
    [Abstract] [Full Text] [Related]

  • 2. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
    Lee JH, Kim TH, Park HE, Lee EG, Jung NC, Song JY, Seo HG, Seung KB, Chang K, Lim DS.
    Cardiovasc Res; 2014 Feb 01; 101(2):203-10. PubMed ID: 24189626
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of dimethyl fumarate on experimental autoimmune myocarditis.
    Milenković M, Arsenović-Ranin N, Vucićević D, Bufan B, Jancić I, Stojić-Vukanić Z.
    Arch Med Res; 2008 Oct 01; 39(7):639-46. PubMed ID: 18760191
    [Abstract] [Full Text] [Related]

  • 4. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
    Liu W, Li WM, Gao C, Sun NL.
    J Autoimmun; 2005 Dec 01; 25(4):258-63. PubMed ID: 16242301
    [Abstract] [Full Text] [Related]

  • 5. The neuropeptide cortistatin attenuates experimental autoimmune myocarditis via inhibition of cardiomyogenic T cell-driven inflammatory responses.
    Delgado-Maroto V, Falo CP, Forte-Lago I, Adan N, Morell M, Maganto-Garcia E, Robledo G, O'Valle F, Lichtman AH, Gonzalez-Rey E, Delgado M.
    Br J Pharmacol; 2017 Feb 01; 174(3):267-280. PubMed ID: 27922195
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.
    Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U.
    Circ Res; 2009 Aug 28; 105(5):462-70. PubMed ID: 19628793
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.
    Blyszczuk P, Behnke S, Lüscher TF, Eriksson U, Kania G.
    Biochim Biophys Acta; 2013 Apr 28; 1833(4):934-44. PubMed ID: 23103516
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sulfated polysaccharide fucoidan ameliorates experimental autoimmune myocarditis in rats.
    Tanaka K, Ito M, Kodama M, Tomita M, Kimura S, Hoyano M, Mitsuma W, Hirono S, Hanawa H, Aizawa Y.
    J Cardiovasc Pharmacol Ther; 2011 Mar 28; 16(1):79-86. PubMed ID: 21193680
    [Abstract] [Full Text] [Related]

  • 18. Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice.
    Tajiri K, Shimojo N, Sakai S, Machino-Ohtsuka T, Imanaka-Yoshida K, Hiroe M, Tsujimura Y, Kimura T, Sato A, Yasutomi Y, Aonuma K.
    Cardiovasc Drugs Ther; 2013 Oct 28; 27(5):413-24. PubMed ID: 23722419
    [Abstract] [Full Text] [Related]

  • 19. Resveratrol ameliorates experimental autoimmune myocarditis.
    Yoshida Y, Shioi T, Izumi T.
    Circ J; 2007 Mar 28; 71(3):397-404. PubMed ID: 17322642
    [Abstract] [Full Text] [Related]

  • 20. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis.
    Cruz-Adalia A, Jiménez-Borreguero LJ, Ramírez-Huesca M, Chico-Calero I, Barreiro O, López-Conesa E, Fresno M, Sánchez-Madrid F, Martín P.
    Circulation; 2010 Oct 05; 122(14):1396-404. PubMed ID: 20855659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.